Lynam Pharma supply pharmaceutical and medical supplies to a range of customers. We are committed to preventing acts of modern slavery and human trafficking within our business and supply chain operations. We have a zero-tolerance approach to all forms of modern slavery, including but not limited to forced, bonded, compulsory labour and human trafficking; we expect the same approach from our customers, suppliers and other operational partners. As part of our commitment to combatting modern slavery and human trafficking, we will develop and maintain internal policies and procedures as part of our due diligence and supply chain assessment process to reinforce our approach whether or not our supply chain partners are subject to scrutiny according to the thresholds set out in the Modern Slavery Act 2015.

 

As part of our commitment to continuous improvement our policies, processes and controls will be reviewed on a regular basis to ensure they remain in line with, or exceed, current legislation; we are committed to acting ethically and with integrity in all our business dealings which include, but are not limited to, modern slavery taking place anywhere in our own business or within our supply chain. We take a risk-based approach and will develop our processes to incorporate new, existing, key and high-risk suppliers who will be encouraged to adopt and uphold the same approach to their own supply chains.

In addition, and in accordance with our ethical stance, we also understand the importance of

educating our own employees on human rights issues and will ensure that all relevant personnel are trained to recognise and report acts of modern slavery, human trafficking and business malpractice accordingly.

This statement is made in accordance with Section 54(1) of the Modern Slavery Act 2015 and

constitutes our anti-slavery and human trafficking statement until such time as the act or similar legislation require an amendment.